Correlation Between Microbot Medical and Entravision Communications

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microbot Medical and Entravision Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microbot Medical and Entravision Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microbot Medical and Entravision Communications, you can compare the effects of market volatilities on Microbot Medical and Entravision Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microbot Medical with a short position of Entravision Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microbot Medical and Entravision Communications.

Diversification Opportunities for Microbot Medical and Entravision Communications

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Microbot and Entravision is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Microbot Medical and Entravision Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entravision Communications and Microbot Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microbot Medical are associated (or correlated) with Entravision Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entravision Communications has no effect on the direction of Microbot Medical i.e., Microbot Medical and Entravision Communications go up and down completely randomly.

Pair Corralation between Microbot Medical and Entravision Communications

Given the investment horizon of 90 days Microbot Medical is expected to generate 2.52 times less return on investment than Entravision Communications. But when comparing it to its historical volatility, Microbot Medical is 1.07 times less risky than Entravision Communications. It trades about 0.05 of its potential returns per unit of risk. Entravision Communications is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  201.00  in Entravision Communications on September 17, 2024 and sell it today you would earn a total of  48.00  from holding Entravision Communications or generate 23.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Microbot Medical  vs.  Entravision Communications

 Performance 
       Timeline  
Microbot Medical 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Microbot Medical may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Entravision Communications 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Entravision Communications are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Entravision Communications exhibited solid returns over the last few months and may actually be approaching a breakup point.

Microbot Medical and Entravision Communications Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microbot Medical and Entravision Communications

The main advantage of trading using opposite Microbot Medical and Entravision Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microbot Medical position performs unexpectedly, Entravision Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entravision Communications will offset losses from the drop in Entravision Communications' long position.
The idea behind Microbot Medical and Entravision Communications pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Transaction History
View history of all your transactions and understand their impact on performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals